What were the main drivers of UnitedHealth Group's revenue growth in 2022?

Revenue growth in 2022 was primarily driven by an increase in the number of people served across both Medicare Advantage and Medicaid programs within UnitedHealthcare, alongside the continued growth of Optum's various businesses, particularly Optum Health and Optum Rx. Pricing trends and expansion of services also contributed significantly.

How is the company managing medical costs, and what is the medical care ratio (MCR)?

UnitedHealth Group manages medical costs through strategies like underwriting, product design, provider contract negotiations, and care management programs. The medical costs increased due to the growth in people served. The Medical Care Ratio (MCR) for 2022 was 82.0%, a slight decrease from 82.6% in 2021, influenced by the ongoing effects of COVID-19 and changes in prior year favorable development and business mix.

What is the significance of the acquisition of Change Healthcare?

The acquisition of Change Healthcare, completed in October 2022 for $13.9 billion, is intended to connect and simplify core clinical, administrative, and payment processes across the healthcare system. Change Healthcare's technologies and capabilities are expected to enhance workflow and transactional connectivity, aiming to create a more efficient and integrated health care ecosystem for providers and payers.

What are the key risks and uncertainties facing UnitedHealth Group?

Key risks include the inability to accurately estimate, price for, and manage medical costs, which could impact profitability on risk-based products. Other significant risks involve maintaining data integrity and system availability, potential cyber-attacks and data security breaches, intense competition within the healthcare market, challenges in managing relationships with healthcare providers, and navigating complex and evolving regulatory environments at both federal and state levels, particularly concerning Medicare and Medicaid funding.

UNH 10-K FY2022 Annual Report — Revenue, Net Income, EPS

Summary

UnitedHealth Group Inc. (UNH) demonstrated robust financial performance in 2022, with consolidated revenues increasing by 13% to $324.2 billion. This growth was driven by strong performance across both its UnitedHealthcare and Optum segments, with Optum revenues growing 17% and UnitedHealthcare revenues growing 12%. The company also saw a significant increase in earnings from operations, up 19%, and diluted earnings per share rose 17% to $21.18. The company continues to expand its reach, serving nearly 1.1 million more people through its UnitedHealthcare offerings, particularly in community-based and senior care. The Optum segment, comprising Optum Health, Optum Insight, and Optum Rx, showed substantial growth, reflecting its expanding role in care delivery, data analytics, and pharmacy services. Cash flow from operations remained strong at $26.2 billion, and the company maintained a healthy return on equity of 27.2%, indicating efficient use of shareholder capital.

Financial Highlights

55 data points

Beta

Revenue

$324.16B

0.9% Gross Margin

Net Income

$20.12B

0.1% Net Margin

EPS (Diluted)

$21.18

Total Assets

$245.71B

Cash & Equivalents

$23.36B

Free Cash Flow

$23.40B

Financial Statements

Beta

Revenue	$324.16B
Cost of Revenue	$33.70B
Gross Profit	$290.46B
SG&A Expenses	$47.78B
Operating Expenses	$295.73B
Operating Income	$28.43B
Interest Expense	$2.09B
Net Income	$20.12B
EPS (Basic)	$21.47
EPS (Diluted)	$21.18
Shares Outstanding (Basic)	937.00M
Shares Outstanding (Diluted)	950.00M

Key Highlights

1Consolidated revenues grew 13% to $324.2 billion in 2022, driven by a 17% increase in Optum revenues and a 12% increase in UnitedHealthcare revenues.
2Diluted earnings per share increased 17% to $21.18, reflecting strong operational performance across the company.
3UnitedHealthcare expanded its member base by approximately 1.1 million people, with notable growth in Medicare Advantage and Medicaid offerings.
4Optum Health saw revenue growth of 32%, driven by value-based care arrangements and business combinations, serving approximately 102 million people.
5Optum Rx managed $124 billion in pharmaceutical spending and fulfilled 1.44 billion adjusted scripts, showing growth in volume and services.
6Cash flow from operations was robust at $26.2 billion, providing significant financial flexibility.
7Return on equity stood at a strong 27.2%, indicating effective capital utilization.

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2022

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions